-
MEDIPOST opts for CDMO business
2022.11.21 -
Is the world biosimilar leader Celltrion eyeing ADCs as its growth driver?
2022.11.16 -
Hanall Biopharma wins a flurry of export bonanza after rigorous R&D efforts foll..
2022.11.15 -
Following FDA orphan drug designation, the sector pictures a rosy future with vi..
2022.11.10 -
Korean pharma companies take bold steps in patents, with LG Chem and Hanmi Pharm..
2022.11.10 -
Global CDMO, Samsung Biologics opens the world’s largest factory
2022.11.10 -
The Future of Drug Delivery Platform, MDimune Inc.
2022.10.31 -
SK biotech expands CDMO capabilities
2022.10.31 -
K-biotech enterprises pursue localization strategies
2022.10.25 -
With novel drugs emerging as the next “big thing,” will K-biotech support prove ..
2022.10.21 -
Multi-national companies enter the Korean biotechnology market
2022.10.19 -
GS Group making relentless strides
2022.10.12 -
MDimune signs a technology export contract with US biotech company
2022.10.11 -
The Autoimmune Specialists’ CRO with State-of-the-Art Solutions, Preclina Inc!
2022.10.04 -
As US intends to nurture its own bio industry, biofoundries draw attention
2022.10.04 -
Curing diseases with microorganisms, “Microbiome”
2022.09.30 -
A blueprint of MediRama’s CDRO
2022.09.30 -
Hanmi's Rolontis becomes the first South Korean new anticancer drug to receive U..
2022.09.29 -
Boryung confidently expected the highest annual sales
2022.09.21 -
New drug development with AI
2022.09.20